FDA approves Purdue Pharma’s Palladone
hydrochloride) capsules for the management of persistent moderate
to severe pain in patients requiring continuous opioid pain
relief for an extended period of time.
There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.